The United States Approves the World’s First Vaccine for Respiratory Syncytial Virus
The U.S. Food and Drug Administration (FDA) has approved Arexvy, the world's first vaccine against respiratory syncytial virus (RSV). This marks a significant scientific breakthrough in the 60-year history of ...
